The Report Includes an Industry wide Assessment of the Novel Product
Launches, Recent Approvals, Research and Development Pipeline, and
Blockbuster Drugs

This report provides detailed exposure of the cardiovascular drugs
market, highlighting major cardiovascular diseases with detailed
epidemiology for the primary disease areas. The report includes an
industry wide assessment of the novel product launches, recent
approvals, research and development pipeline, and blockbuster drugs.

Strict regulations are imposed on cardiovascular drugs and the report
discusses the regional regulatory landscape for these drugs. This
includes products approved by the regulatory authorities in recent
years. Products under development or that are in different stages of
clinical trials are analyzed in the pipeline assessment section.

Cardiovascular drug delivery systems are also included in the report,
such as nanoparticle-mediated drug delivery, gene therapy and cell
therapy, among others.

A discussion of the major players is included in the competitive
landscape section, which looks at trends in product launches,
collaborations, mergers and acquisitions, and other agreements. Company
profiles of major players operating in the cardiovascular drugs market
include overviews, key product offerings, financials, strategies, SWOT
analysis, and new research and development strategies.

The report will be particularly useful to readers in its thorough
analysis of the leading products and will enable readers to recognize
growing brands, key drug classes, and leading manufacturing companies
with significant market share.

Report Includes:

52 data tables and 48 additional tables

An overview of the global market for cardiovascular drugs

Analyses of global market trends, with data from 2016 and 2017, and
projections of compound annual growth rates (CAGRs) through 2022

A look at the regulatory environment, which has been a driving force
in drug development

Information on competitor initiatives, and information with regard to
demand for specialty chemicals used to develop new products and for
new applications

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her
physician.